Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 7.20 INR
Change Today 0.00 / 0.00%
Volume 0.0
BAP On Other Exchanges
Symbol
Exchange
Mumbai
As of 6:00 AM 08/3/15 All times are local (Market data is delayed by at least 15 minutes).

bacil pharma ltd (BAP) Snapshot

Open
7.20
Previous Close
7.20
Day High
7.20
Day Low
7.20
52 Week High
10/21/14 - 9.22
52 Week Low
08/4/14 - 2.62
Market Cap
42.4M
Average Volume 10 Days
2.1K
EPS TTM
-0.05
Shares Outstanding
5.9M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for BACIL PHARMA LTD (BAP)

Related News

No related news articles were found.

bacil pharma ltd (BAP) Related Businessweek News

No Related Businessweek News Found

bacil pharma ltd (BAP) Details

Bacil Pharma Limited engages in the trading activities. Bacil Pharma Limited was incorporated in 1987 and is based in Mumbai, India.

Founded in 1987

bacil pharma ltd (BAP) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

bacil pharma ltd (BAP) Key Developments

Bacil Pharma Ltd, Board Meeting, Jul 02, 2015

Bacil Pharma Ltd, Board Meeting, Jul 02, 2015. Agenda: To consider and approve audited results.

Bacil Pharma Ltd. Reports Unaudited Standalone Earnings Results for the Fourth Quarter and Year Ended March 31, 2015

Bacil Pharma Ltd. reported unaudited standalone earnings results for the fourth quarter and year ended March 31, 2015. For the quarter, the company’s loss from operations before other income, interest and exceptional items was INR 0.332 million compared to INR 0.988 million a year ago. Loss from ordinary activities before tax was INR 0.050 million compared to INR 0.814 million a year ago. Net loss for the period was INR 0.050 million compared to INR 0.814 million a year ago. For the year, the company’s loss from operations before other income, interest and exceptional items was INR 1.125 million compared to INR 1.672 million a year ago. Loss from ordinary activities before tax was INR 0.318 million compared to INR 1.090 million a year ago. Net loss for the period was INR 0.318 million compared to INR 1.090 million a year ago.

Bacil Pharma Ltd, Board Meeting, May 15, 2015

Bacil Pharma Ltd, Board Meeting, May 15, 2015. Agenda: To consider unaudited standalone earnings results for the fourth quarter and year ended March 31, 2015.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BAP:IN 7.20 INR 0.00

BAP Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for BAP.
View Industry Companies
 

Industry Analysis

BAP

Industry Average

Valuation BAP Industry Range
Price/Earnings NM Not Meaningful
Price/Sales -- Not Meaningful
Price/Book 0.5x
Price/Cash Flow NM Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BACIL PHARMA LTD, please visit www.bacilpharma.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.